{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:51:24Z","timestamp":1783824684258,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.canlet.2022.215829","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T02:13:37Z","timestamp":1658196817000},"page":"215829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING\/MAVS signaling pathway"],"prefix":"10.1016","volume":"545","author":[{"given":"Jiwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5430-303X","authenticated-orcid":false,"given":"Shengli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enjiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4240-8333","authenticated-orcid":false,"given":"Yutao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0493-8322","authenticated-orcid":false,"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2022.215829_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","article-title":"Recent global patterns in prostate cancer incidence and mortality rates","volume":"77","author":"30207593Culp","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2022.215829_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2022.215829_bib3","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMe1912750","article-title":"Hormonal therapy or chemotherapy for metastatic prostate cancer - playing the right CARD","volume":"381","author":"Eisenberger","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2022.215829_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.eururo.2016.05.002","article-title":"Docetaxel activity in the era of life-prolonging hormonal therapies for metastatic castration-resistant prostate cancer","volume":"70","author":"Francini","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2022.215829_bib5","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/annonc\/mdq050","article-title":"Docetaxel-based combination therapy for castration-resistant prostate cancer","volume":"21","author":"Galsky","year":"2010","journal-title":"Ann. Oncol. : official journal of the European Society for Medical Oncology"},{"key":"10.1016\/j.canlet.2022.215829_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cell.2013.06.020","article-title":"lincRNAs: genomics, evolution, and mechanisms","volume":"154","author":"Ulitsky","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2022.215829_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","article-title":"RNA in cancer","volume":"21","author":"Goodall","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2022.215829_bib8","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cell.2013.02.012","article-title":"Long noncoding RNAs: cellular address codes in development and disease","volume":"152","author":"Batista","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2022.215829_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","article-title":"Therapeutic targeting of long non-coding RNAs in cancer","volume":"24","author":"Arun","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2022.215829_bib10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/365764a0","article-title":"Tumour-suppressor activity of H19 RNA","volume":"365","author":"Hao","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215829_bib11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/hep.29145","article-title":"The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2022.215829_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13073-015-0233-4","article-title":"HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer","volume":"7","author":"Teschendorff","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.canlet.2022.215829_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-020-01162-0","article-title":"Long non-coding RNAs regulate drug resistance in cancer","volume":"19","author":"Liu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215829_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12943-018-0852-7","article-title":"Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star","volume":"17","author":"Xu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215829_bib15","doi-asserted-by":"crossref","first-page":"15321","DOI":"10.18632\/oncotarget.4148","article-title":"Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells","volume":"6","author":"Bansal","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2022.215829_bib16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2022.215829_bib17","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1101\/gr.221077.117","article-title":"Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies","volume":"27","author":"Geeleher","year":"2017","journal-title":"Genome Res."},{"key":"10.1016\/j.canlet.2022.215829_bib18","article-title":"Integrated characterization of lncRNA-immune interactions in prostate cancer","volume":"9","author":"Hu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2022.215829_bib19","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/hep.31530","article-title":"Gain of LINC00624 enhances liver cancer progression by disrupting the histone deacetylase 6\/tripartite motif containing 28\/zinc finger protein 354C corepressor complex","volume":"73","author":"Li","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2022.215829_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ni921","article-title":"IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway","volume":"4","author":"Fitzgerald","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2022.215829_bib21","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1126\/science.1081315","article-title":"Triggering the interferon antiviral response through an IKK-related pathway","volume":"300","author":"Sharma","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.canlet.2022.215829_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/14728222.2019.1601702","article-title":"TANK-binding kinase 1 as a novel therapeutic target for viral diseases","volume":"23","author":"Zhao","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.canlet.2022.215829_bib23","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.celrep.2013.01.034","article-title":"Crystal structure and mechanism of activation of TANK-binding kinase 1","volume":"3","author":"Larabi","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2022.215829_bib24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.celrep.2013.01.033","article-title":"Structure and ubiquitination-dependent activation of TANK-binding kinase 1","volume":"3","author":"Tu","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2022.215829_bib25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.febslet.2013.01.052","article-title":"Negative regulation of TBK1-mediated antiviral immunity","volume":"587","author":"Zhao","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2022.215829_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2002521","article-title":"STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway","volume":"5","author":"Tanaka","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2022.215829_bib27","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41593-019-0505-1","article-title":"Age-related hyperinsulinemia leads to insulin resistance in neurons and cell-cycle-induced senescence","volume":"22","author":"Chow","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.canlet.2022.215829_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/blood.2018874560","article-title":"Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma","volume":"134","author":"Wu","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2022.215829_bib29","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41588-021-00964-2","article-title":"A cis-acting mechanism mediates transcriptional memory at Polycomb target genes in mammals","volume":"53","author":"Holoch","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2022.215829_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41588-021-00804-3","article-title":"Human-chimpanzee fused cells reveal cis-regulatory divergence underlying skeletal evolution","volume":"53","author":"Gokhman","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2022.215829_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI136098","article-title":"N-cadherin upregulation mediates adaptive radioresistance in glioblastoma","volume":"131","author":"Osuka","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2022.215829_bib32","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.ymthe.2018.02.012","article-title":"Human ISL1(+) ventricular progenitors self-assemble into an in vivo functional heart patch and preserve cardiac function post infarction","volume":"26","author":"Foo","year":"2018","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.canlet.2022.215829_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101970","article-title":"Activation of NRF2 by APE1\/REF1 is redox-dependent in Barrett's related esophageal adenocarcinoma cells","volume":"43","author":"Sriramajayam","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2022.215829_bib34","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.cytogfr.2014.06.006","article-title":"The mechanism of double-stranded DNA sensing through the cGAS-STING pathway","volume":"25","author":"Shu","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.canlet.2022.215829_bib35","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2022.215829_bib36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","article-title":"High-risk prostate cancer-classification and therapy","volume":"11","author":"Chang","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2022.215829_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1101\/gad.334516.119","article-title":"PARP and PARG inhibitors in cancer treatment","volume":"34","author":"Slade","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2022.215829_bib38","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1101\/gad.315739.118","article-title":"Genetics and biology of prostate cancer","volume":"32","author":"Wang","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2022.215829_bib39","first-page":"5","article-title":"Prostate cancer between prognosis and adequate\/proper therapy","volume":"10","author":"Grozescu","year":"2017","journal-title":"Journal of medicine and life"},{"key":"10.1016\/j.canlet.2022.215829_bib40","first-page":"7","volume":"F1000Research","author":"Ritch","year":"2018"},{"key":"10.1016\/j.canlet.2022.215829_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02977789","article-title":"Induction of phase I, II and III drug metabolism\/transport by xenobiotics","volume":"28","author":"Xu","year":"2005","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.canlet.2022.215829_bib42","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.7150\/thno.25541","article-title":"Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19","volume":"8","author":"Ren","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2022.215829_bib43","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/ijc.32319","article-title":"Long noncoding RNA HOTAIR promotes invasion of breast cancer cells through chondroitin sulfotransferase CHST15","volume":"145","author":"Liu","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2022.215829_bib44","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1038\/sj.onc.1210266","article-title":"Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells","volume":"26","author":"Tsang","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2022.215829_bib45","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1158\/1541-7786.MCR-13-0636","article-title":"Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy","volume":"12","author":"Takahashi","year":"2014","journal-title":"Mol. Cancer Res. : MCR"},{"key":"10.1016\/j.canlet.2022.215829_bib46","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biopha.2018.02.130","article-title":"LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation","volume":"101","author":"Fang","year":"2018","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.canlet.2022.215829_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1476-4598-12-131","article-title":"The long non-coding RNA ERIC is regulated by E2F and modulates the cellular response to DNA damage","volume":"12","author":"Feldstein","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215829_bib48","first-page":"276","article-title":"Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer","volume":"41","author":"Wang","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2022.215829_bib49","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/onc.2014.144","article-title":"Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer","volume":"34","author":"Orfanelli","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2022.215829_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.omtn.2019.02.010","article-title":"LINC00665 induces acquired resistance to gefitinib through recruiting EZH2 and activating PI3K\/AKT pathway in NSCLC, molecular therapy","volume":"16","author":"Liu","year":"2019","journal-title":"Nucleic acids"},{"key":"10.1016\/j.canlet.2022.215829_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.celrep.2015.08.069","article-title":"LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional Program and drives castration-resistant prostate cancer","volume":"13","author":"Zhang","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2022.215829_bib52","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522003135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522003135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:04:51Z","timestamp":1759593891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383522003135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":52,"alternative-id":["S0304383522003135"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215829","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING\/MAVS signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"215829"}}